Dr. Gary Kobinger wins prestigious Manning Innovation Award

$100,000 prize for developing antiviral against deadly Ebola Virus Disease

Gary Kobinger.jpg
Photo: Mary McCown

Dr. Gary Kobinger, Director of the Center for Research on Infectious Diseases at Université Laval, and Dr. Qiu Xiangguo of the Public Health Agency of Canada in Winnipeg, are the winners of the prestigious Ernest C. Manning Awards Foundation Principal Innovation Award.

The Ernest C. Manning Awards Foundation recently announced that Dr. Gary Kobinger of Quebec City and his research partner, Dr. Xiangguo Qiu, have won the 2017 Manning Innovation Principal Award for developing ZMapp™, the world’s first Ebola Virus Disease antiviral. The award was presented at the Manning Innovation Symposium held in Toronto on Nov. 30.